IIM
ZNTL icon

INTECH Investment Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

INTECH Investment Management’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.7K Buy
+10,460
New +$41.8K ﹤0.01% 2050
2025
Q2 		– Sell
-40,279
Closed -$64K – 2690
2025
Q1 		$64K Buy
40,279
+12,241
+44% +$26.4K ﹤0.01% 2402
2024
Q4 		$85K Buy
28,038
+7,631
+37% +$25K ﹤0.01% 2246
2024
Q3 		$75.1K Buy
+20,407
New +$74.2K ﹤0.01% 1935

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

INTECH Investment Management's ZNTL Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q2 2026: 10,460 shares worth $50.7K. The stake represents ﹤0.01% of the portfolio and ranks #2050 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in ZNTL as recently as Q1 2025.

INTECH Investment Management first reported a position in ZNTL in Q3 2024 and has held it in 4 quarters since. The position peaked at $85K in Q4 2024. 114 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

  • INTECH Investment Management held 10,460 shares of Zentalis Pharmaceuticals worth $50.7K as of Q2 2026.
  • Zentalis Pharmaceuticals was a new INTECH Investment Management position in Q2 2026.
  • Zentalis Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2050 holding.
  • INTECH Investment Management first reported a position in Zentalis Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • INTECH Investment Management's Zentalis Pharmaceuticals position peaked at $85K in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.